Exicure, Inc. financial data

Symbol
XCUR on Nasdaq
Industry
Pharmaceutical Preparations
Location
2430 N. Halsted St., Chicago, IL
State of incorporation
DE
Fiscal year end
December 31
Former names
Max-1 Acquisition Corp (to 9/28/2017)
Latest financial report
10-K - Q4 2024 - Mar 18, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 155 % -31.5%
Debt-to-equity 288 % +168%
Return On Equity -320 % -50.5%
Return On Assets -82.4 % +19.6%
Operating Margin 23.4 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.32M shares -27%
Common Stock, Shares, Outstanding 6.03M shares +229%
Entity Public Float 7.6M USD +31%
Common Stock, Value, Issued 1K USD
Weighted Average Number of Shares Outstanding, Basic 2.04M shares +27.5%
Weighted Average Number of Shares Outstanding, Diluted 2.04M shares +27.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD -100%
Revenue from Contract with Customer, Excluding Assessed Tax 500K USD
Research and Development Expense 0 USD -100%
General and Administrative Expense 5.45M USD -53.5%
Operating Income (Loss) -12.2M USD +18.4%
Nonoperating Income (Expense) 2.54M USD +3609%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -9.69M USD +42.7%
Income Tax Expense (Benefit) 8K USD
Net Income (Loss) Attributable to Parent -9.7M USD +42.6%
Earnings Per Share, Basic -4.75 USD/shares +55%
Earnings Per Share, Diluted -4.75 USD/shares +55%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 343K USD -62.8%
Assets, Current 13.7M USD +576%
Property, Plant and Equipment, Net 26K USD -51.9%
Operating Lease, Right-of-Use Asset 0 USD -100%
Other Assets, Noncurrent 1.36M USD -54.5%
Assets 15.1M USD +30%
Accounts Payable, Current 1.03M USD -36.8%
Employee-related Liabilities, Current 0 USD -100%
Accrued Liabilities, Current 2.04M USD +132%
Liabilities, Current 3.07M USD +22.4%
Operating Lease, Liability, Noncurrent 5.21M USD -13.7%
Liabilities 8.28M USD -3.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -199M USD -5.12%
Stockholders' Equity Attributable to Parent 6.77M USD +123%
Liabilities and Equity 15.1M USD +30%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -450K USD +86.4%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities 0 USD -100%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 6.03M shares +229%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -450K USD -133%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12.5M USD +520%
Deferred Tax Assets, Valuation Allowance 6.92M USD +62.8%
Operating Lease, Liability 5.94M USD -11%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -16.9M USD -556%
Lessee, Operating Lease, Liability, to be Paid 7.37M USD -14.4%
Property, Plant and Equipment, Gross 279K USD 0%
Operating Lease, Liability, Current 722K USD +15.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.31M USD +3.07%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.17M USD +3%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.44M USD -26.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.35M USD +2.98%
Deferred Tax Assets, Operating Loss Carryforwards 3.96M USD +25.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.39M USD +3.04%
Operating Lease, Payments 0 USD -100%
Additional Paid in Capital 206M USD +6.98%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 132K USD -93.9%
Share-based Payment Arrangement, Expense 22K USD -98.4%
Interest Expense 0 USD -100%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%